Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway

Correction: Mol Cancer 14, 99 (2015)

https://doi.org/10.1186/s12943-015-0346-9

Following publication of the original article [1], the authors reported inadvertent errors in two panels of Figure 3.

The original Figure 3B shows a duplication of a histological image. The duplicated image has been replaced and the images, as well as their labels, have been accurately arranged in the corrected Figure 3. In addition, the attached corrected Figure 3 revises two time point labels in panel E.

The following clarification was added to figure legend 3E: “A portion of the control and ONC201/TIC10 results shown for reference were previously published [26].” The corrected and incorrect figures are given below.

Incorrect Figure 3:

Correct Figure 3:

1. Allen JE, Krigsfeld G, Patel L, et al. Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway. Mol Cancer. 2015;14:99. https://doi.org/10.1186/s12943-015-0346-9.

   Article PubMed PubMed Central Google Scholar

Download references

Authors and Affiliations

1. Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, 19104, PA, USA

   Joshua E Allen, Gabriel Krigsfeld, Luv Patel, Patrick A Mayes, David T Dicker & Wafik S El-Deiry

2. Current affiliation: Oncoceutics, Inc., Hummelstown, PA, USA

   Joshua E Allen

3. Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, 19111, PA, USA

   David T Dicker & Wafik S El-Deiry

4. Department of Pathology, Program in Molecular Biology and Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, 48201, USA

   Gen Sheng Wu

Authors

1. Joshua E AllenView author publications

   You can also search for this author in PubMed Google Scholar

2. Gabriel KrigsfeldView author publications

   You can also search for this author in PubMed Google Scholar

3. Luv PatelView author publications

   You can also search for this author in PubMed Google Scholar

4. Patrick A MayesView author publications

   You can also search for this author in PubMed Google Scholar

5. David T DickerView author publications

   You can also search for this author in PubMed Google Scholar

6. Gen Sheng WuView author publications

   You can also search for this author in PubMed Google Scholar

7. Wafik S El-DeiryView author publications

   You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wafik S El-Deiry.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

Cite this article

Allen, J.E., Krigsfeld, G., Patel, L. et al. Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway. Mol Cancer 23, 233 (2024). https://doi.org/10.1186/s12943-024-02158-w

Download citation

• Published: 18 October 2024

• DOI: https://doi.org/10.1186/s12943-024-02158-w

Share this article

Anyone you share the following link with will be able to read this content:

Get shareable link

Sorry, a shareable link is not currently available for this article.

Copy to clipboard

Provided by the Springer Nature SharedIt content-sharing initiative